VSee Health secures FedRAMP authorization, expands into ICU robotics

Published 11/11/2025, 14:26
VSee Health secures FedRAMP authorization, expands into ICU robotics

SAN JOSE, CALIFORNIA - VSee Health, Inc. (NASDAQ:VSEE) has obtained FedRAMP Moderate authorization for its telehealth platform, positioning the company to pursue federal government contracts, according to a company press release issued Tuesday. The micro-cap company, valued at just $14.6 million, is making this strategic move while facing significant financial challenges, including a current ratio of 0.11 indicating short-term obligations exceed liquid assets.

The telehealth technology provider is also expanding into intensive care units with robotic assistance systems that allow remote clinicians to monitor patients and intervene in real-time.

"Telehealth isn't just convenient anymore; it's essential for saving lives and bending the healthcare cost curve," said Dr. Imo Aisiku, Co-CEO of VSee Health. "Our FedRAMP milestone opens doors to massive government contracts."

The company reports a 150% year-over-year increase in enterprise deployments. Its platform now supports multiple visit types, remote examinations, and electronic health record integrations.

VSee recently secured a contract to expand public mental health services in one of the nation's largest counties, the company stated.

The U.S. telehealth market is projected to reach $52.76 billion in 2025 and grow at a 23.84% compound annual growth rate through 2034, according to figures cited in the announcement.

VSee Health provides telehealth technology and services through its platform, serving hospital systems, health networks, and employers across the United States.

In other recent news, VSee Health, Inc. has made notable strides in expanding its services and securing important agreements. The company announced a three-year contract to provide virtual urgent care and behavioral health services to a major non-profit academic health system, covering over 100 hospitals and outpatient centers. This agreement, set to begin in 2026, has no revenue ceiling, potentially increasing VSee's revenue streams. Additionally, VSee Health has completed over 100,000 radiology reads through its teleradiology platform, which is currently operational in 18 hospitals, with plans to expand to 35 hospitals by the end of the year.

Furthermore, VSee Health has received FedRAMP High authorization from the U.S. Department of Health and Human Services, enabling its telehealth platform to be utilized by federal agencies requiring high security standards. This certification opens up significant expansion opportunities within government sectors. The company is also exploring healthcare collaboration in the Philippines, meeting with local officials to discuss digital health initiatives in Naga City. These discussions aim to improve healthcare delivery, particularly in addressing low prenatal check-up rates.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.